CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale BRISTOW MICHAEL R sold 5,446 shares at $0.71 ($3,884)
- 4 Open-market sale VP, Finance sold 1,125 shares at $0.71 ($800)
- 4 Grant or award Chief Operating Officer acquired 25,350 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award S.V.P., General Counsel acquired 24,050 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 48,100 shares (grant or award)
- 4 Grant or award VP, Finance acquired 23,400 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 350,000 shares at an average $0.76 ($267,500)
- 4 Open-market sale 10% owner sold 550,000 shares at an average $0.92 ($503,500)
Page 12 of 23 · 459 filings